Prevymis (letermovir) - Merck (MSD)
Nulojix (belatacept) - BMS
Updates in pediatric kidney transplantation. (PubMed, Curr Opin Organ Transplant) - Mar 25, 2026 - "Transplant teams should consider using a broader range of donor organs in select pediatric patients. Further interventional research on peritransplant thromboprophylaxis and fluid management is needed to optimize management strategies. The completion of ongoing belatacept and letermovir trials have the potential to substantially alter posttransplant standards of care." 
Journal • Cytomegalovirus Infection • Nephrology • Pediatrics • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41869824
 
Rachel M Engen
 
Mar 25, 2026
 
Prev Next